ODI Pharma AB has an EPS of $-0.45. In 2022, the company made an earnings per share (EPS) of $-0.48. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.45 | -6.25% |
2022 | -$0.48 | 84.62% |
2021 | -$0.26 | -27.78% |
2020 | -$0.36 | - |